Developer docs
API playgroundTry for free, no card

Search company profiles

Wavelet Medical

Full company profile

uuid00sttic

Namestring
Wavelet Medical
Legal namestring
Wavelet Medical
Websiteurl
wavelet.co
Company typeenum
Private
Founded yearint
2026
Descriptiontext

Wavelet Medical is a New Haven-based, Yale University spin-out developing the first non-invasive, AI-powered fetal electroencephalography (EEG) monitoring platform. The company's core product is a hardware-and-software system that places sensors on the mother's abdomen and applies proprietary machine learning algorithms to reconstruct fetal brain activity in real time, enabling clinicians to detect neurological distress directly rather than relying on indirect fetal heart rate monitoring — a method that the company states is indeterminate in up to 85% of births. The intended use cases span detection of preventable brain injuries at birth and reduction of unnecessary Caesarean sections driven by inconclusive monitoring data.

The technology stack is built around proprietary signal-reconstruction ML models trained on EEG data, with claimed capabilities in real-time anomaly detection and predictive analytics for fetal neurological outcomes. As of April 2026, the platform is being validated clinically at three sites — Yale University, LA General Hospital/USC, and Yonsei University Health System in South Korea — with approximately 300 patients enrolled. The company has secured $7 million in seed funding led by Aegis Ventures (April 2026) under a co-creation partnership intended to accelerate global commercial expansion, and has stated a near-term goal of deploying at five to seven U.S. hospitals across urban and rural settings.

Wavelet Medical operates as a pre-revenue B2B medical device business targeting hospitals, academic medical centers, and healthcare systems as its primary customer segment, with a planned enterprise field-sales motion. Its revenue model is hardware sales of the fetal monitoring platform to healthcare providers, though pricing has not been publicly disclosed and no commercial contracts are yet in place. Distribution today is limited to direct pilot partnerships with clinical research sites; commercialization is expected to leverage the Aegis Ventures partnership for global scaling.

Short descriptiontext

Wavelet Medical is a Yale University spin-out building an AI-powered, non-invasive fetal EEG monitoring platform that uses proprietary machine learning to reconstruct fetal brain activity from abdominal sensors and detect neurological distress in real time for hospital and obstetric care providers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew Haven, United States
HQ citystring
New Haven
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fetal EEG monitoring, AI medical devices, non-invasive brain monitoring, obstetric diagnostic equipment, fetal neurology analytics
Industry6 codes
PRIMARYHLAHACAF
Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAFAC
Maternal & Neonatal Remote Monitoring Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLACAPAG
Maternal, Neonatal & Pediatric Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAFAG
Maternal & High-Risk Pregnancy Remote Monitoring (BP, glucose, fetal/uterine monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLAKAJAB
Maternal-Fetal Medicine (High-Risk Pregnancy/Perinatology)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Fetal Monitoring Medical Devices
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Revenue model not explicitly disclosed in sources. Company appears to be in early-stage pilot phase with clinical validation trials underway, with plans for global commercial expansion through hospital/healthcare system sales.

prnewswire.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components2 values
Technology or R&D, Personnel
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Wavelet Medical develops and sells a non-invasive fetal electroencephalography (EEG) monitoring platform that uses proprietary AI and machine learning algorithms to reconstruct fetal brain activity from abdominal sensors. The platform detects fetal neurological distress in real time during pregnancy, enabling obstetricians to make timely clinical decisions aimed at preventing brain injuries at birth and reducing unnecessary Caesarean sections. The product is currently being validated in clinical trials at Yale University, LA General Hospital/USC, and Yonsei University Health System.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Traditional heart rate monitoring is indeterminate in up to 85% of births
+2 more records
Product overview1 text field

Wavelet Medical offers a single unified product: its AI-powered non-invasive fetal EEG monitoring platform. This platform directly measures fetal brain activity through the mother's abdomen using EEG technology combined with machine learning algorithms to detect neurological distress in real time, addressing the limitations of traditional heart rate monitoring which is indeterminate in up to 85% of births. The platform is currently being piloted at three clinical sites and aims to expand to five to seven U.S. hospitals in urban and rural areas.

Product and service1 record
1AI Fetal Brain Monitoring Platform
CategoryFetal Monitoring Medical Device
Description

A non-invasive fetal EEG monitoring platform that uses proprietary AI algorithms and machine learning to reconstruct and analyze fetal brain activity from abdominal sensors, detecting neurological distress in real time to improve birth outcomes. Designed for hospitals, academic medical centers, and obstetric departments.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-14
Description

Co-creation partnership with Aegis Ventures to accelerate global commercial expansion. Aegis Ventures released whitepaper highlighting Wavelet Medical as a portfolio company demonstrating AI-native medical device capabilities. Partnership includes $7M seed funding and strategic support for scaling the technology globally.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-14
Description

Technology developed at and spun out from Yale University. Yale serves as a clinical trial site for the non-invasive fetal EEG monitoring platform. Parent institution relationship providing ongoing research collaboration and clinical validation.

3LA General Hospital/USC
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-13
Description

Clinical trial site partner for AI-powered fetal EEG monitoring platform. Conducts clinical validation research alongside academic medical center for technology testing and refinement.

fiercehealthcare.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-13
Description

International clinical trial site in South Korea for fetal monitoring technology. Part of multi-site clinical validation involving approximately 300 patients across U.S. and international locations.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specializes in neurodiagnostic and neonatal monitoring devices, including EEG systems used in clinical settings. Highly comparable to Wavelet's EEG-based neurological monitoring technology stack and hospital GTM motion.

TypeBroad incumbent
Description

Provides the Avalon fetal monitor series alongside a broad portfolio of patient monitoring and connected care solutions. A key incumbent competitor with deep hospital integration and global reach.

TypeDirect peer
Description

Manufactures EEG and sleep diagnostic systems with AI-assisted analysis for clinical use. Comparable as a neurology-focused EEG platform vendor targeting hospital and clinical customers.

TypeBroad incumbent
Description

A major incumbent offering fetal monitoring products (e.g., Centricity, Corometrics) within a broad portfolio of hospital imaging and monitoring solutions. Represents the dominant installed base Wavelet must displace.

TypeDirect peer
Description

Develops AI-powered EEG-based devices for brain injury assessment. Closely comparable to Wavelet in applying machine learning to EEG signals for clinical neurological decision-making.

6Edan Instruments
TypeBroad incumbent
Description

Provides a broad range of patient and fetal monitoring devices globally with growing presence in U.S. hospital channels. Comparable as an incumbent fetal monitoring device competitor.

TypeBroad incumbent
Description

Diversified patient monitoring company with EEG brain monitoring products (SedLine) alongside its core pulse oximetry franchise. Comparable as an AI-enabled hospital monitoring platform with neurological applications.

TypeBroad incumbent
Description

Major global medical device company offering fetal and patient monitoring systems across both developed and emerging markets. Represents both a competitor and a potential strategic channel partner for Wavelet.

9Monica Healthcare
TypeDirect peer
Description

Focused on non-invasive fetal monitoring technology for use during labor and pregnancy. Closely comparable to Wavelet's mission of advancing fetal monitoring beyond conventional approaches.

TypeDirect peer
Description

Specializes in STAN fetal monitoring for assessment of fetal wellbeing during labor. Comparable as a fetal monitoring technology company targeting the same obstetric hospital segment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wavelet Medical

Fetal Monitoring Medical Deviceswavelet.co

Wavelet Medical is a Yale University spin-out building an AI-powered, non-invasive fetal EEG monitoring platform that uses proprietary machine learning to reconstruct fetal brain activity from abdominal sensors and detect neurological distress in real time for hospital and obstetric care providers.

What Wavelet Medical does

Wavelet Medical is a New Haven-based, Yale University spin-out developing the first non-invasive, AI-powered fetal electroencephalography (EEG) monitoring platform. The company's core product is a hardware-and-software system that places sensors on the mother's abdomen and applies proprietary machine learning algorithms to reconstruct fetal brain activity in real time, enabling clinicians to detect neurological distress directly rather than relying on indirect fetal heart rate monitoring — a method that the company states is indeterminate in up to 85% of births. The intended use cases span detection of preventable brain injuries at birth and reduction of unnecessary Caesarean sections driven by inconclusive monitoring data.

The technology stack is built around proprietary signal-reconstruction ML models trained on EEG data, with claimed capabilities in real-time anomaly detection and predictive analytics for fetal neurological outcomes. As of April 2026, the platform is being validated clinically at three sites — Yale University, LA General Hospital/USC, and Yonsei University Health System in South Korea — with approximately 300 patients enrolled. The company has secured $7 million in seed funding led by Aegis Ventures (April 2026) under a co-creation partnership intended to accelerate global commercial expansion, and has stated a near-term goal of deploying at five to seven U.S. hospitals across urban and rural settings.

Wavelet Medical operates as a pre-revenue B2B medical device business targeting hospitals, academic medical centers, and healthcare systems as its primary customer segment, with a planned enterprise field-sales motion. Its revenue model is hardware sales of the fetal monitoring platform to healthcare providers, though pricing has not been publicly disclosed and no commercial contracts are yet in place. Distribution today is limited to direct pilot partnerships with clinical research sites; commercialization is expected to leverage the Aegis Ventures partnership for global scaling.

Wavelet Medical firmographics

Firmographics
Name
Wavelet Medical
Legal name
Wavelet Medical
Website
https://wavelet.co
Company type
Private
Founded year
2026
Operating status
Operating
Headcount range
1–10 employees
Short description
Wavelet Medical is a Yale University spin-out building an AI-powered, non-invasive fetal EEG monitoring platform that uses proprietary machine learning to reconstruct fetal brain activity from abdominal sensors and detect neurological distress in real time for hospital and obstetric care providers.
Ownership category
akta.pro rank

Wavelet Medical industry classification

Industry
Product category
Fetal Monitoring Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHACAF
Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAFAC
Maternal & Neonatal Remote Monitoring Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLACAPAG
Maternal, Neonatal & Pediatric Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAFAG
Maternal & High-Risk Pregnancy Remote Monitoring (BP, glucose, fetal/uterine monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLAKAJAB
Maternal-Fetal Medicine (High-Risk Pregnancy/Perinatology)

Keywords

  • Fetal EEG monitoring
  • AI medical devices
  • Non-invasive brain monitoring
  • Obstetric diagnostic equipment
  • Fetal neurology analytics

Where Wavelet Medical is headquartered

Location

Headquarters

HQ city
New Haven
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Wavelet Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel

Revenue model

  1. Medical Device Sales: Revenue model not explicitly disclosed in sources. Company appears to be in early-stage pilot phase with clinical validation trials underway, with plans for global commercial expansion through hospital/healthcare system sales.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Wavelet Medical product offering

Product offering

Core offering

Wavelet Medical develops and sells a non-invasive fetal electroencephalography (EEG) monitoring platform that uses proprietary AI and machine learning algorithms to reconstruct fetal brain activity from abdominal sensors. The platform detects fetal neurological distress in real time during pregnancy, enabling obstetricians to make timely clinical decisions aimed at preventing brain injuries at birth and reducing unnecessary Caesarean sections. The product is currently being validated in clinical trials at Yale University, LA General Hospital/USC, and Yonsei University Health System.

Product overview

Wavelet Medical offers a single unified product: its AI-powered non-invasive fetal EEG monitoring platform. This platform directly measures fetal brain activity through the mother's abdomen using EEG technology combined with machine learning algorithms to detect neurological distress in real time, addressing the limitations of traditional heart rate monitoring which is indeterminate in up to 85% of births. The platform is currently being piloted at three clinical sites and aims to expand to five to seven U.S. hospitals in urban and rural areas.

Differentiator

Problem solved

Functional benefit

Products and services

  • AI Fetal Brain Monitoring Platform A non-invasive fetal EEG monitoring platform that uses proprietary AI algorithms and machine learning to reconstruct and analyze fetal brain activity from abdominal sensors, detecting neurological distress in real time to improve birth outcomes. Designed for hospitals, academic medical centers, and obstetric departments.

Quantifiable outcome

  • Traditional heart rate monitoring is indeterminate in up to 85% of births
  • +2 more outcomes

Companies that use Wavelet Medical

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Wavelet Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Wavelet Medical partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • Aegis VenturescoreStrategic or Co-development Partner · 14 April 2026Co-creation partnership with Aegis Ventures to accelerate global commercial expansion. Aegis Ventures released whitepaper highlighting Wavelet Medical as a portfolio company demonstrating AI-native medical device capabilities. Partnership includes $7M seed funding and strategic support for scaling the technology globally.
  • Yale UniversitycoreStrategic or Co-development Partner · 14 April 2026Technology developed at and spun out from Yale University. Yale serves as a clinical trial site for the non-invasive fetal EEG monitoring platform. Parent institution relationship providing ongoing research collaboration and clinical validation.
  • LA General Hospital/USCcoreStrategic or Co-development Partner · 13 April 2026Clinical trial site partner for AI-powered fetal EEG monitoring platform. Conducts clinical validation research alongside academic medical center for technology testing and refinement.
  • Yonsei University Health SystemcoreStrategic or Co-development Partner · 13 April 2026International clinical trial site in South Korea for fetal monitoring technology. Part of multi-site clinical validation involving approximately 300 patients across U.S. and international locations.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Wavelet Medical competitors and assessment

Company assessment

Direct peers

  • Natus Medical: Specializes in neurodiagnostic and neonatal monitoring devices, including EEG systems used in clinical settings. Highly comparable to Wavelet's EEG-based neurological monitoring technology stack and hospital GTM motion.
  • Compumedics: Manufactures EEG and sleep diagnostic systems with AI-assisted analysis for clinical use. Comparable as a neurology-focused EEG platform vendor targeting hospital and clinical customers.
  • BrainScope: Develops AI-powered EEG-based devices for brain injury assessment. Closely comparable to Wavelet in applying machine learning to EEG signals for clinical neurological decision-making.
  • Monica Healthcare: Focused on non-invasive fetal monitoring technology for use during labor and pregnancy. Closely comparable to Wavelet's mission of advancing fetal monitoring beyond conventional approaches.
  • Neoventa Medical: Specializes in STAN fetal monitoring for assessment of fetal wellbeing during labor. Comparable as a fetal monitoring technology company targeting the same obstetric hospital segment.

Broad incumbents

  • Philips Healthcare: Provides the Avalon fetal monitor series alongside a broad portfolio of patient monitoring and connected care solutions. A key incumbent competitor with deep hospital integration and global reach.
  • GE Healthcare: A major incumbent offering fetal monitoring products (e.g., Centricity, Corometrics) within a broad portfolio of hospital imaging and monitoring solutions. Represents the dominant installed base Wavelet must displace.
  • Edan Instruments: Provides a broad range of patient and fetal monitoring devices globally with growing presence in U.S. hospital channels. Comparable as an incumbent fetal monitoring device competitor.
  • Masimo: Diversified patient monitoring company with EEG brain monitoring products (SedLine) alongside its core pulse oximetry franchise. Comparable as an AI-enabled hospital monitoring platform with neurological applications.
  • Mindray: Major global medical device company offering fetal and patient monitoring systems across both developed and emerging markets. Represents both a competitor and a potential strategic channel partner for Wavelet.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Wavelet Medical social profiles

Digital presence

Wavelet Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wavelet Medical leadership team

Management profile

Number of profiles

Profiles2 records

Wavelet Medical funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wavelet Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wavelet Medical

What does Wavelet Medical do?

Wavelet Medical develops and sells a non-invasive fetal electroencephalography (EEG) monitoring platform that uses proprietary AI and machine learning algorithms to reconstruct fetal brain activity from abdominal sensors. The platform detects fetal neurological distress in real time during pregnancy, enabling obstetricians to make timely clinical decisions aimed at preventing brain injuries at birth and reducing unnecessary Caesarean sections. The product is currently being validated in clinical trials at Yale University, LA General Hospital/USC, and Yonsei University Health System.

Is Wavelet Medical a public or private company?

Wavelet Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Wavelet Medical founded?

Wavelet Medical was founded in 2026. It employs 1 to 10 people.

Where is Wavelet Medical based?

Wavelet Medical is headquartered in New Haven, United States, in the North America region.

How does Wavelet Medical make money?

One revenue line is on record: medical Device Sales.

Who are Wavelet Medical's main competitors?

Direct peers on record are Natus Medical, Compumedics, BrainScope, Monica Healthcare and Neoventa Medical. Broad incumbents are Philips Healthcare, GE Healthcare, Edan Instruments, Masimo and Mindray.

Does Wavelet Medical have an API?

No public API is recorded for Wavelet Medical.

What industry is Wavelet Medical in?

Wavelet Medical's product category is Fetal Monitoring Medical Devices. Its primary akta.pro industry code is HLAHACAF, Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables), with a secondary code of HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireWavelet Medical Receives ARPA-H Award to Support Validation of Novel Fetal Brain Monitoring TechnologyWavelet Medical announced receipt of a $2.14 million award from the Advanced Research Projects Agency for Health (ARPA-H) over 12 months to support validation of its non-invasive, AI-powered fetal brain monitoring technology. The platform uses abdominal EEG to detect fetal brain distress in real time, addressing a gap in current obstetrics where fetal heart rate monitoring fails to directly measure neurological function and is indeterminate in up to 85% of births. The technology is currently being tested at three clinical sites, with the company preparing for expanded trials.MedTech InnovatorWavelet Medical Receives ARPA-H Award to Support Validation of Novel Fetal Brain Monitoring TechnologyWavelet Medical received an ARPA-H award of up to $2.14M over 12 months to validate its non-invasive AI-powered fetal EEG monitoring platform. The technology aims to detect fetal brain distress in real time, addressing limitations of fetal heart rate monitoring. The award commences in June.HIT ConsultantReimagining Medical Devices in the AI Era: The Three Structural Shifts Driving Venture-Scale GrowthAegis Ventures released a whitepaper analyzing how the medical device sector has historically captured only 2% to 3% of U.S. healthcare venture capital despite representing a $200 billion annual market, with exit timelines spanning 12 to 17 years. The report identifies three structural shifts driven by AI integration: expanding total addressable markets through multi-application hardware platforms, enabling generalists to perform specialist-level diagnostics, and building compounding data moats that create defensible competitive advantages. The paper highlights portfolio companies Optain Health and Wavelet Medical as proof points demonstrating how AI-native medical devices can overcome traditional venture capital constraints.FinSMEsWavelet Medical Raises $7M in Seed FundingWavelet Medical, a New Haven-based healthcare startup, raised $7M in seed funding from Aegis Ventures. The company, founded by Liz Golden and others, develops an AI-powered non-invasive fetal EEG platform to detect neurological distress. It is currently being tested at three clinical sites and preparing for expanded trials.HIT ConsultantWavelet Medical Secures $7M to Scale AI Fetal Brain MonitoringWavelet Medical, an AI-powered fetal brain monitoring startup spun out of Yale, has raised $7M in seed funding and entered a co-creation partnership with Aegis Ventures to accelerate global commercial expansion. The company has developed a non-invasive fetal EEG monitoring platform that uses proprietary AI algorithms to reconstruct fetal brain activity from abdominal sensors, detecting neurological distress in real time. The platform is currently being piloted at three clinical sites including Yale University, LA General Hospital/USC, and Yonsei University Health System in South Korea.PR NewswireAegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal MedicineWavelet Medical has partnered with Aegis Ventures to commercialize a non-invasive, AI-powered fetal EEG monitoring platform developed at Yale, backed by $7 million in seed funding. The technology directly measures fetal brain activity through the mother's abdomen to detect neurological distress in real time, addressing limitations of traditional heart rate monitoring which is indeterminate in up to 85% of births. The partnership aims to scale the technology globally, with clinical trials currently underway at three U.S. sites, potentially redefining the standard of care in fetal medicine.FierceHealthcareWavelet Medical, Aegis Ventures partner on first AI non-invasive fetal EEG monitoring platformWavelet Medical and Aegis Ventures have partnered to co-create and scale the first AI-powered non-invasive fetal EEG monitoring platform, designed to detect fetal brain distress in real-time and reduce preventable brain injuries at birth and unnecessary Caesarean sections. The platform has secured $7 million in seed funding and is currently being tested at three clinical sites — Yale University, LA General Hospital, and Korea's Yonsei University Health System — with approximately 300 patients enrolled, aiming to expand to five to seven U.S. hospitals in urban and rural areas.